{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:41:54Z","timestamp":1785368514696,"version":"3.55.0"},"reference-count":45,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"4","license":[{"start":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T00:00:00Z","timestamp":1639526400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. La dermatitis at\u00f3pica es una enfermedad cut\u00e1nea cr\u00f3nica e intermitente muy frecuente, con un impacto cl\u00ednico evidente en la calidad de vida de los pacientes. No hay estudios locales que describan las caracter\u00edsticas generales de esta condici\u00f3n en nuestra poblaci\u00f3n.Objetivo. Evaluar las caracter\u00edsticas sociodemogr\u00e1ficas, cl\u00ednicas y de calidad de vida en pacientes con dermatitis at\u00f3pica residentes en Medell\u00edn y su \u00e1rea metropolitana.Materiales y m\u00e9todos. Se hizo un estudio transversal descriptivo de pacientes que consultaron en algunos centros de referencia de la ciudad de Medell\u00edn, a quienes se les hizo una encuesta sobre variables sociodemogr\u00e1ficas y cl\u00ednicas. Adem\u00e1s, se evalu\u00f3 la seriedad cl\u00ednica de la enfermedad y su impacto en la calidad de vida.Resultados. Se incluyeron 113 pacientes, de los cuales 36,3 % manifest\u00f3 tener alg\u00fan trastorno del sue\u00f1o, 38,1 % report\u00f3 d\u00e9ficit de atenci\u00f3n y 44,2 % inform\u00f3 haber sufrido asma en la infancia. Se registr\u00f3 un puntaje promedio de 6,9 en el \u00edndice EASI (Eczema Area and Severity Index) y de 32,4 en el SCORAD (Scoring Atopic Dermatitis), es decir, el compromiso cl\u00ednico era de leve a moderado. Con el cuestionario Skindex-29, se encontraron promedios de 37,7, 25,09 y 16,9 para los dominios sintom\u00e1tico, emocional y funcional, respectivamente, con un promedio total de 24,78. En el cuestionario EuroQol 5 Dimensions (EQ-5D), el componente m\u00e1s importante fue la presencia de dolor o malestar (17,6 %) y de ansiedad o depresi\u00f3n (12,1 %).Conclusi\u00f3n. Los resultados obtenidos confirmaron que la poblaci\u00f3n analizada con dermatitis at\u00f3pica presentaba caracter\u00edsticas similares a las reportadas en otras partes del mundo, con un impacto neuropsiqui\u00e1trico y emocional en aspectos como el sue\u00f1o.<\/jats:p>","DOI":"10.7705\/biomedica.5978","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T13:18:12Z","timestamp":1630588692000},"page":"676-691","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":12,"title":["Caracterizaci\u00f3n cl\u00ednica, sociodemogr\u00e1fica y determinaci\u00f3n del impacto en la calidad de vida de pacientes con dermatitis at\u00f3pica de la ciudad de Medell\u00edn y su \u00e1rea metropolitana"],"prefix":"10.7705","volume":"41","author":[{"given":"Miguel Mateo","family":"Cuervo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Sanclemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina Marcela","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4444","published-online":{"date-parts":[[2021,12,15]]},"reference":[{"key":"106741","doi-asserted-by":"crossref","unstructured":"Wallach D, Ta\u00efeb A. Atopic dermatitis\/atopic eczema. Chem Immunol Allergy. 2014;100:81-96. https:\/\/doi.org\/10.1159\/000358606","DOI":"10.1159\/000358606"},{"key":"106742","doi-asserted-by":"crossref","unstructured":"McPherson T. Current understanding in pathogenesis of atopic dermatitis. Indian J Dermatol. 2016;61:649-55. https:\/\/doi.org\/10.4103\/0019-5154.193674","DOI":"10.4103\/0019-5154.193674"},{"key":"106743","doi-asserted-by":"crossref","unstructured":"Sullivan M, Silverberg NB. Current and emerging concepts in atopic dermatitis pathogenesis. Clin Dermatol. 2017;35:349-53. https:\/\/doi.org\/10.1016\/j.clindermatol.2017.03.006","DOI":"10.1016\/j.clindermatol.2017.03.006"},{"key":"106744","unstructured":"Busi FM. Barrera epid\u00e9rmica en dermatitis at\u00f3pica. Rev Asoc Colomb Dermatolog\u00eda. 2008;16:293-301."},{"key":"106745","doi-asserted-by":"crossref","unstructured":"Kirchhof MG, Landells I, Lynde CW, Gooderham MJ, Hong CH. Approach to the assessment and management of adult patients with atopic dermatitis: A consensus document. Section I: Pathophysiology of atopic dermatitis and implications for systemic therapy. J Cutan Med Surg. 2018;22:6S-9S. https:\/\/doi.org\/10.1177\/1203475418803626","DOI":"10.1177\/1203475418803626"},{"key":"106746","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Simpson EL. Associations of childhood eczema severity: A US populationbased study. Dermatitis. 2014;25:107-14. https:\/\/doi.org\/10.1097\/DER.0000000000000034","DOI":"10.1097\/DER.0000000000000034"},{"key":"106747","doi-asserted-by":"crossref","unstructured":"Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-58.e23. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.009","DOI":"10.1016\/j.jaci.2009.10.009"},{"key":"106748","doi-asserted-by":"crossref","unstructured":"Dennis R, Caraballo L, Garc\u00eda E, Caballero A, Aristiz\u00e1bal G, C\u00f3rdoba H, et al. Asthma and other allergic conditions in Colombia: A study in 6 cities. Ann Allergy Asthma Immunol. 2004;93:56-74. https:\/\/doi.org\/10.1016\/S1081-1206(10)61265-3","DOI":"10.1016\/S1081-1206(10)61265-3"},{"key":"106749","doi-asserted-by":"crossref","unstructured":"Dennis RJ, Caraballo L, Garc\u00eda E, Rojas MX, Rond\u00f3n MA, P\u00e9rez A, et al. Prevalence of asthma and other allergic conditions in Colombia 2009 - 2010: A cross-sectional study. BMC Pulm Med. 2012;12:1-9. https:\/\/doi.org\/10.1186\/1471-2466-12-17","DOI":"10.1186\/1471-2466-12-17"},{"key":"106750","doi-asserted-by":"crossref","unstructured":"Ezzedine K, Kechichian E. \u00c9pid\u00e9miologie de la dermatite atopique. Ann Dermatol Venereol. 2017;144:VS4-7. https:\/\/doi.org\/10.1016\/S0151-9638(18)30085-1","DOI":"10.1016\/S0151-9638(18)30085-1"},{"key":"106751","unstructured":"Catalina S, Restrepo M, Mej\u00eda CC, William J, Ochoa C. Prevalencia de alergias en ni\u00f1os entre 5 y 14 a\u00f1os con trastorno de d\u00e9ficit de atenci\u00f3n e hiperactividad. Medell\u00edn, 2012. Acta Neurol\u00f3gica Colomb. 2014;30:156-62.: http:\/\/www.scielo.org.co\/pdf\/anco\/v30n3\/v30n3a05.pdf"},{"key":"106752","doi-asserted-by":"crossref","unstructured":"Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109-22. https:\/\/doi.org\/10.1016\/S0140-6736(15)00149-X","DOI":"10.1016\/S0140-6736(15)00149-X"},{"key":"106753","doi-asserted-by":"crossref","unstructured":"Thomsen SF. Atopic dermatitis: Natural history, diagnosis, and treatment. ISRN Allergy. 2014;2014:354250. https:\/\/doi.org\/10.1155\/2014\/354250","DOI":"10.1155\/2014\/354250"},{"key":"106754","unstructured":"Rivero JI. Dermatitis at\u00f3pica. Rev M\u00e9dica Costa Rica y Centroam\u00e9rica. 2016;LXXIII(620):711-6."},{"key":"106755","doi-asserted-by":"crossref","unstructured":"DaVeiga SP. Epidemiology of atopic dermatitis: A review. Allergy Asthma Proc 2012;33:227-34. https:\/\/doi.org\/10.2500\/aap.2012.33.3569","DOI":"10.2500\/aap.2012.33.3569"},{"key":"106756","doi-asserted-by":"crossref","unstructured":"Tagani H. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis. J Dermatol. 2014;29:398. https:\/\/doi.org\/10.1111\/j.1346-8138.2002.tb00292.x","DOI":"10.1111\/j.1346-8138.2002.tb00292.x"},{"key":"106757","doi-asserted-by":"crossref","unstructured":"Hanifin JM, Cooper KD, Ho VC, Kang S, Krafchik BR, Margolis DJ, et al. Guidelines of care for atopic dermatitis. J Am Acad Dermatol. 2004;50:391-404. https:\/\/doi.org\/10.1016\/j.jaad.2003.08.003","DOI":"10.1016\/j.jaad.2003.08.003"},{"key":"106758","doi-asserted-by":"crossref","unstructured":"Vakharia PP, Chopra R, Silverberg JL. Systematic review of diagnostic criteria used in atopic dermatitis randomized controlled trials. Am J Clin Dermatol. 2018;19:15-22. https:\/\/doi.org\/10.1007\/s40257-017-0299-4","DOI":"10.1007\/s40257-017-0299-4"},{"key":"106759","doi-asserted-by":"crossref","unstructured":"Sanclemente G, Garc\u00eda H, Aguirre D, Jones M, Lugo L, Escobar C, et al. Fiabilidad y validez de constructo de la versi\u00f3n colombiana del instrumento de calidad de vida Skindex-29\u00a9 en Medell\u00edn, Colombia. Iatreia. 2017;30:21-33.","DOI":"10.17533\/udea.iatreia.v30n1a02"},{"key":"106760","doi-asserted-by":"crossref","unstructured":"Tofte S, Graeber M, Cherill R, Omoto M, Thurston M, Hanifin JM. Eczema area and severity index (EASI): A new tool to evaluate atopic dermatitis. J Eur Acad Dermatology Venereol. 1998;11:S197. https:\/\/doi.org\/10.1016\/S0926-9959(98)95291-6","DOI":"10.1016\/S0926-9959(98)95291-6"},{"key":"106761","doi-asserted-by":"crossref","unstructured":"Boguniewicz M, Fonacier L, Guttman-Yassky E, Ong PY, Silverberg J, Farrar JR. Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape. Ann Allergy Asthma Immunol. 2018;120:10-22.e2. https:\/\/doi.org\/10.1016\/j.anai.2017.10.039","DOI":"10.1016\/j.anai.2017.10.039"},{"key":"106762","doi-asserted-by":"crossref","unstructured":"Atherton DJ, Bieber T, Bonifazi E, Broberg A, Calza A, Coleman R, et al. Severity scoring of atopic dermatitis: The SCORAD index. Dermatology. 1993;186:23-32. https:\/\/doi.org\/10.1159\/000247298","DOI":"10.1159\/000247298"},{"key":"106763","doi-asserted-by":"crossref","unstructured":"Sanclemente G, Burgos C, Nova J, Hern\u00e1ndez F, Gonz\u00e1lez C, Reyes MI, et al. The impact of skin diseases on quality of life: A multicenter study. Actas Dermo-Sifiliogr\u00e1ficas. 2017;108:244-52. https:\/\/doi.org\/10.1016\/j.adengl.2016.11.019","DOI":"10.1016\/j.ad.2016.11.008"},{"key":"106764","doi-asserted-by":"crossref","unstructured":"Herdman M, Badia X, Berra S. El EuroQol-5D: una alternativa sencilla para la medici\u00f3n de la calidad de vida relacionada con la salud en atenci\u00f3n primaria. Atenci\u00f3n Primaria. 2001;28:425-9.","DOI":"10.1016\/S0212-6567(01)70406-4"},{"key":"106765","doi-asserted-by":"crossref","unstructured":"Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, Fink-Wagner A, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatology Venereol. 2018;32:657-82. https:\/\/doi.org\/10.1111\/jdv.14891","DOI":"10.1111\/jdv.14891"},{"key":"106766","doi-asserted-by":"crossref","unstructured":"Sy W, Lamb AJ. Atopic dermatitis disease education. In: Fortson EA, et al., editor. Management of atopic dermatitis, advances in experimental medicine and biology. 1st edition. New York: Springer International Publishing; 2017. p. 179-84.","DOI":"10.1007\/978-3-319-64804-0_14"},{"key":"106767","doi-asserted-by":"crossref","unstructured":"Dhadwal G, Albrecht L, Gniadecki R, Poulin Y, Yeung J, Hong CH, et al. Approach to the assessment and management of adult patients with atopic dermatitis: A consensus document. Section IV: Treatment options for the management of atopic dermatitis. J Cutan Med Surg. 2018;22:21S-9S. https:\/\/doi.org\/10.1177\/1203475418803627","DOI":"10.1177\/1203475418805721"},{"key":"106768","doi-asserted-by":"crossref","unstructured":"Calzavara P, Cristaudo A, Foti C, Canonica GW, Balato N, Costanzo A, et al. Diagnosis and management of moderate to severe adult atopic dermatitis: A consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Cli. G Ital Dermatol Venereol. 2018;153:13345. https:\/\/doi.org\/10.23736\/S0392-0488.17.05892","DOI":"10.23736\/S0392-0488.17.05892-8"},{"key":"106769","unstructured":"Gonz\u00e1lez P, L\u00e1zaro M, Llaneza J, Luca de T \u00c1, Ortiz JM, Palacios D, et al. Informe Grupo de Trabajo Dermatitis at\u00f3pica: del diagn\u00f3stico a la definici\u00f3n de una ruta asistencial. Madrid: Fundamed; 2019. p. 1-40."},{"key":"106770","unstructured":"Sanclemente G, Mahecha M, Guzm\u00e1n C. Enfermedades de la piel m\u00e1s frecuentes en la consulta dermatol\u00f3gica del Hospital Universitario San Vicente de Pa\u00fal y del Hospital Infantil Medell\u00edn, 1999. Acta M\u00e9dica Colomb. 2001;26:240-5."},{"key":"106771","doi-asserted-by":"crossref","unstructured":"Pyun BY. Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res. 2014;7:101-5. https:\/\/doi.org\/10.4168\/aair.2015.7.2.101","DOI":"10.4168\/aair.2015.7.2.101"},{"key":"106772","doi-asserted-by":"crossref","unstructured":"Silverberg JL. Comorbidities and the impact of atopic dermatitis. Ann Allergy Asthma Immunol. 2019;123:144-51. https:\/\/doi.org\/10.1016\/j.anai.2019.04.020","DOI":"10.1016\/j.anai.2019.04.020"},{"key":"106773","doi-asserted-by":"crossref","unstructured":"Davis DM, Waldman A, Jacob S, LeBovidge J, Ahluwalia J, Tollefson M, et al. Diagnosis, comorbidity, and psychosocial impact of atopic dermatitis. Semin Cutan Med Surg. 2017;36:95-9. https:\/\/doi.org\/10.12788\/j.sder.2017.028","DOI":"10.12788\/j.sder.2017.028"},{"key":"106774","doi-asserted-by":"crossref","unstructured":"Paller A, Jaworski JC, Simpson EL, Boguniewicz M, Russell JJ, Block JK, et al. Major comorbidities of atopic dermatitis: Beyond allergic disorders. Am J Clin Dermatol. 2018;19:821-38. https:\/\/doi.org\/10.1007\/s40257-018-0383-4","DOI":"10.1007\/s40257-018-0383-4"},{"key":"106775","doi-asserted-by":"crossref","unstructured":"Andersen YMF, Egeberg A, Skov L, Thyssen JP. Comorbidities of atopic dermatitis: Beyond rhinitis and asthma. Curr Dermatol Rep. 2017;6:35-41. https:\/\/doi.org\/10.1007\/s13671-017-0168-7","DOI":"10.1007\/s13671-017-0168-7"},{"key":"106776","doi-asserted-by":"crossref","unstructured":"Ravn NH, Halling AS, Berkowitz AG, Rinnov MR, Silverberg JI, Egeberg A, et al. How does parental history of atopic disease predict the risk of atopic dermatitis in a child? A systematic review and meta-analysis. J Allergy Clin Immunol. 2020;145:1182-93. https:\/\/doi.org\/10.1016\/j.jaci.2019.12.899","DOI":"10.1016\/j.jaci.2019.12.899"},{"key":"106777","doi-asserted-by":"crossref","unstructured":"B\u00f6hme M, Wickman M, Nordvall SL, Svartengren M, Wahlgren CF. Family history and risk of atopic dermatitis in children up to 4 years. Clin Exp Allergy. 2003;33:1226-31. https:\/\/doi.org\/10.1046\/j.1365-2222.2003.01749.x","DOI":"10.1046\/j.1365-2222.2003.01749.x"},{"key":"106778","doi-asserted-by":"crossref","unstructured":"Sicras-Mainar A, Navarro-Artieda R, Carrascosa-Carrillo JM. Impacto econ\u00f3mico de la dermatitis at\u00f3pica en adultos: estudio de base poblacional (estudio IDEA). Actas Dermosifiliogr. 2018;109:35-46. https:\/\/doi.org\/10.1016\/j.ad.2017.09.003","DOI":"10.1016\/j.ad.2017.09.003"},{"key":"106779","doi-asserted-by":"crossref","unstructured":"Chopra R, Vakharia PP, Sacotte R, Patel N, Immaneni S, White T, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017;177:1316-21. https:\/\/doi.org\/10.1111\/bjd.15641","DOI":"10.1111\/bjd.15641"},{"key":"106780","doi-asserted-by":"crossref","unstructured":"Chu H, Shin JU, Park CO, Lee H, Lee J, Lee KH. Clinical diversity of atopic dermatitis: Review of 5,000 patients with atopic dermatitis at a single institute. Allergy Asthma Immunol Res. 2017;9:158-68. https:\/\/doi.org\/10.4168\/aair.2017.9.2.158%0Ahttp:\/\/e-aair.org","DOI":"10.4168\/aair.2017.9.2.158"},{"key":"106781","unstructured":"Adegbidi H, Akpadjan F, Atadokpede F, Degboe B, Agbessi N, Koudoukpo C, et al. Stigmata of atopy in children in Dermatology-Venereology Department of National University Hospital Center Hubert Koutoukou Maga of Cotonou. Skin Dis Skin Care. 2017;23:3-5."},{"key":"106782","unstructured":"Przybilla B, Bauer C. Stigmata of the atopic constitution. In: Ring J, Przybilla B, Ruzicka T, editors. Handbook of the atopic eczema. Berlin: Springer; 2006. p. 61-73."},{"key":"106783","doi-asserted-by":"crossref","unstructured":"Nankervis H, Thomas KS, Delamere FM, Barbarot S, Rogers NK, Williams HC. Scoping systematic review of treatments for eczema. Program Grants Appl Res. 2016;4:1-480. https:\/\/doi.org\/10.3310\/pgfar04070","DOI":"10.3310\/pgfar04070"},{"key":"106784","doi-asserted-by":"crossref","unstructured":"Gooderham MJ, Hong HC ho, Eshtiaghi P, Papp KA. Dupilumab: A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol. 2018;78:S28-36. https:\/\/doi.org\/10.1016\/j.jaad.2017.12.022","DOI":"10.1016\/j.jaad.2017.12.022"},{"key":"106785","doi-asserted-by":"crossref","unstructured":"Egu\u00edluz-Gracia I, Robledo-Echarren T, Su\u00e1rez-Fern\u00e1ndez R, Fern\u00e1ndez-Rivas M, S\u00e1nchez-Ram\u00f3n S. Omalizumab for the treatment of atopic dermatitis. Clin Investig (Lond). 2015;5:121-36. https:\/\/doi.org\/10.4155\/CLI.14.108","DOI":"10.4155\/cli.14.108"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5978\/4984","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/5978\/4984","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T19:18:46Z","timestamp":1640114326000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/5978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,15]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,15]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.5978","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"value":"2590-7379","type":"electronic"},{"value":"0120-4157","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,15]]},"assertion":[{"value":"2021-12-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Original article","name":"content_type","label":"Content Type"}]}}